Goudot C, Coillard A, Villani A-C, et al. Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus Macrophages. Immunity. 2017;47(3):582-596.e6. doi:10.1016/j.immuni.2017.08.016.

Viswanathan SR, Nogueira MF, Buss CG, et al. Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer. Nat Genet. 2018;50(7):937-943. doi:10.1038/s41588-018-0155-3.

Giacomelli AO, Yang X, Lintner RE, et al. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat Genet. 2018;50(10):1381-1387. doi:10.1038/s41588-018-0204-y.

Sarkizova S, Hacohen N. How T cells spot tumour cells. Nature. 2017;551(7681):444-446. doi:10.1038/d41586-017-07267-9.

Way GP, Sanchez-Vega F, La K, et al. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. Cell Rep. 2018;23(1):172-180.e3. doi:10.1016/j.celrep.2018.03.046.

Frank SR, Köllmann CP, Luong P, et al. p190 RhoGAP promotes contact inhibition in epithelial cells by repressing YAP activity. J Cell Biol. 2018;217(9):3183-3201. doi:10.1083/jcb.201710058.

Chalmers ZR, Connelly CF, Fabrizio D, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34. doi:10.1186/s13073-017-0424-2.

Mayers JR, Heiden MGV. Nature and Nurture: What Determines Tumor Metabolic Phenotypes?. Cancer Res. 2017;77(12):3131-3134. doi:10.1158/0008-5472.CAN-17-0165.

Taylor-Weiner A, Stewart C, Giordano T, et al. DeTiN: overcoming tumor-in-normal contamination. Nat Methods. 2018;15(7):531-534. doi:10.1038/s41592-018-0036-9.

Wang LW, Jiang S, Gewurz BE. Epstein-Barr Virus LMP1-Mediated Oncogenicity. J Virol. 2017;91(21). doi:10.1128/JVI.01718-16.